• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】29877

【品名】methyl (5S,8S,11S)-1-(9H-fluoren-9-yl)-8-[(1R)-1-hydroxyethyl]-11-isopropyl-3,6,9-trioxo-5-[(tritylsulfanyl)methyl]-2-oxa-4,7,10-triazadodecan-12-oate

【CA登记号】

【 分 子 式 】C47H49N3O7S

【 分 子 量 】799.98808

【元素组成】C 70.57% H 6.17% N 5.25% O 14% S 4.01%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(II)

(i) The formation of a 16-membered depsipeptide: For the first step, L-valine methyl ester (I) was coupled to N-Fmoc-L-threonine using the BOP reagent [(benzotriazol-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate], removing the N-Fmoc group with Et2NH and coupling to N-Fmoc-(S-triphenylmethyl)-D-cysteine to yield the tripeptide (II). The tetrapeptide (III) was prepared by deprotection of the tripeptide (II) and BOP-mediated peptide coupling of the resulting amine with N-Fmoc-D-valine. The secondary hydroxyl group was activated as the tosylate and eliminated by treatment with DABCO to produce the internal alkene. After removal of the Fmoc protecting group by addition of Et2NH to the reaction mixture, the 16-membered depsipeptide (IV) was formed.

1 Li, K.W.; Simon, J.A.; Xing, W.; Wu, J.; Total synthesis of the antitumor depsipeptide FR901228. J Am Chem Soc 1996, 118, 30, 7237.
2 Wang, H.-C. R.; FR901228. Drugs Fut 1999, 24, 11, 1184.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 16613 methyl (2S)-2-amino-3-methylbutanoate C6H13NO2 详情 详情
(II) 29877 methyl (5S,8S,11S)-1-(9H-fluoren-9-yl)-8-[(1R)-1-hydroxyethyl]-11-isopropyl-3,6,9-trioxo-5-[(tritylsulfanyl)methyl]-2-oxa-4,7,10-triazadodecan-12-oate C47H49N3O7S 详情 详情
(III) 29878 methyl (5R,8S,11S,14S)-1-(9H-fluoren-9-yl)-5,14-diisopropyl-11-((1R)-1-[[(4-methylphenyl)sulfonyl]oxy]ethyl)-3,6,9,12-tetraoxo-8-[(tritylsulfanyl)methyl]-2-oxa-4,7,10,13-tetraazapentadecan-15-oate C59H64N4O10S2 详情 详情
(IV) 29879 methyl (2S)-2-[((Z)-2-[[(2S)-2-[[(2R)-2-amino-3-methylbutanoyl]amino]-3-(tritylsulfanyl)propanoyl]amino]-2-butenoyl)amino]-3-methylbutanoate C37H46N4O5S 详情 详情
Extended Information